Douglas Tsao
Stock Analyst at H.C. Wainwright
(4.86)
# 354
Out of 4,357 analysts
1203
Total ratings
52.8%
Success rate
20.8%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Reiterated: Buy | $1,245 | $335.16 | +271.46% | 54 | Jun 1, 2026 | |
| BHVN Biohaven | Reiterated: Hold | $10 | $11.43 | -12.51% | 21 | Jun 1, 2026 | |
| NMRA Neumora Therapeutics | Reiterated: Buy | $18 | $1.82 | +889.01% | 22 | Jun 1, 2026 | |
| STO: HNSA Hansa Biopharma AB (publ) | Reiterated: Buy | kr 103.00 | $32.62 | +215.76% | 50 | May 26, 2026 | |
| IMVT Immunovant | Reiterated: Buy | $40 | $32.86 | +21.73% | 45 | May 26, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $118 | $71.97 | +63.96% | 35 | May 26, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | $34 | $29.09 | +16.88% | 45 | May 21, 2026 | |
| DARE Daré Bioscience | Reiterated: Buy | $12 | $2.19 | +447.95% | 40 | May 15, 2026 | |
| CABA Cabaletta Bio | Maintained: Buy | $16 | $3.67 | +335.97% | 48 | May 15, 2026 | |
| ALKS Alkermes | Reiterated: Hold | $43 | $42.27 | +1.73% | 56 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.61 | +38.50% | 42 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.57 | +345.86% | 77 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $4.84 | +44.63% | 43 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $117 | $94.92 | +23.26% | 78 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $940 | $836.09 | +12.43% | 63 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $21.47 | +58.36% | 18 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 | $53.41 | +38.55% | 16 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $81 | $34.52 | +134.65% | 62 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $16.96 | +29.72% | 29 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $6.52 | +99.39% | 56 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $22.96 | +65.51% | 28 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.5 | $0.843 | -40.69% | 47 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $37.11 | +7.79% | 10 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $15 | $15.93 | -5.84% | 39 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.08 | +127.64% | 13 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $5 | $0.001 | n/a | 26 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $360 | $0.75 | n/a | 9 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $0.00001 | n/a | 13 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $11.80 | n/a | 4 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.12 | n/a | 19 | Nov 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €19.00 → €11.00 | $4.81 | n/a | 7 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $34.64 | n/a | 12 | Aug 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $31 → $33 | $29.87 | n/a | 2 | Jul 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $93 → $80 | $10.76 | n/a | 8 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $7.36 | n/a | 17 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $12.90 | n/a | 2 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $71 → $77 | $77.56 | n/a | 6 | Feb 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $108 → $120 | $138.03 | n/a | 12 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $186.82 | n/a | 3 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $68.14 | n/a | 3 | Jun 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $47 → $50 | $15.81 | n/a | 6 | May 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 | $232.64 | n/a | 7 | Jan 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $182.07 | n/a | 5 | Nov 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $14 → $2 | $7.77 | n/a | 5 | Nov 16, 2016 |
Praxis Precision Medicines
Jun 1, 2026
Reiterated: Buy
Price Target: $1,245
Current: $335.16
Upside: +271.46%
Biohaven
Jun 1, 2026
Reiterated: Hold
Price Target: $10
Current: $11.43
Upside: -12.51%
Neumora Therapeutics
Jun 1, 2026
Reiterated: Buy
Price Target: $18
Current: $1.82
Upside: +889.01%
Hansa Biopharma AB (publ)
May 26, 2026
Reiterated: Buy
Price Target: kr 103.00
Current: $32.62
Upside: +215.76%
Immunovant
May 26, 2026
Reiterated: Buy
Price Target: $40
Current: $32.86
Upside: +21.73%
Disc Medicine
May 26, 2026
Reiterated: Buy
Price Target: $118
Current: $71.97
Upside: +63.96%
Roivant Sciences
May 21, 2026
Reiterated: Buy
Price Target: $34
Current: $29.09
Upside: +16.88%
Daré Bioscience
May 15, 2026
Reiterated: Buy
Price Target: $12
Current: $2.19
Upside: +447.95%
Cabaletta Bio
May 15, 2026
Maintained: Buy
Price Target: $16
Current: $3.67
Upside: +335.97%
Alkermes
May 13, 2026
Reiterated: Hold
Price Target: $43
Current: $42.27
Upside: +1.73%
May 13, 2026
Reiterated: Buy
Price Target: $5
Current: $3.61
Upside: +38.50%
May 12, 2026
Reiterated: Buy
Price Target: $7
Current: $1.57
Upside: +345.86%
May 11, 2026
Reiterated: Hold
Price Target: $7
Current: $4.84
Upside: +44.63%
May 11, 2026
Reiterated: Buy
Price Target: $117
Current: $94.92
Upside: +23.26%
May 11, 2026
Reiterated: Buy
Price Target: $940
Current: $836.09
Upside: +12.43%
May 11, 2026
Reiterated: Buy
Price Target: $34
Current: $21.47
Upside: +58.36%
May 8, 2026
Reiterated: Buy
Price Target: $74
Current: $53.41
Upside: +38.55%
May 8, 2026
Reiterated: Buy
Price Target: $81
Current: $34.52
Upside: +134.65%
May 6, 2026
Reiterated: Buy
Price Target: $22
Current: $16.96
Upside: +29.72%
May 5, 2026
Maintained: Buy
Price Target: $13
Current: $6.52
Upside: +99.39%
May 4, 2026
Reiterated: Buy
Price Target: $38
Current: $22.96
Upside: +65.51%
Apr 8, 2026
Reiterated: Hold
Price Target: $0.5
Current: $0.843
Upside: -40.69%
Mar 11, 2026
Reiterated: Buy
Price Target: $40
Current: $37.11
Upside: +7.79%
Mar 4, 2026
Rated: Buy
Price Target: $20 → $15
Current: $15.93
Upside: -5.84%
Nov 6, 2025
Reiterated: Buy
Price Target: $7
Current: $3.08
Upside: +127.64%
Nov 14, 2024
Downgraded: Hold
Price Target: $125 → $5
Current: $0.001
Upside: n/a
Oct 1, 2024
Reiterated: Buy
Price Target: $360
Current: $0.75
Upside: n/a
Aug 21, 2023
Reiterated: Buy
Price Target: $4 → $3
Current: $0.00001
Upside: n/a
Mar 8, 2023
Maintained: Hold
Price Target: $6
Current: $11.80
Upside: n/a
Nov 30, 2022
Rated: Hold
Price Target: n/a
Current: $2.12
Upside: n/a
Nov 1, 2022
Reiterated: Buy
Price Target: €19.00 → €11.00
Current: $4.81
Upside: n/a
Aug 6, 2018
Maintained: Hold
Price Target: $23
Current: $34.64
Upside: n/a
Jul 3, 2018
Maintained: Sell
Price Target: $31 → $33
Current: $29.87
Upside: n/a
Jun 6, 2018
Downgraded: Hold
Price Target: $93 → $80
Current: $10.76
Upside: n/a
Jun 6, 2018
Upgraded: Buy
Price Target: n/a
Current: $7.36
Upside: n/a
May 1, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $12.90
Upside: n/a
Feb 16, 2018
Maintained: Hold
Price Target: $71 → $77
Current: $77.56
Upside: n/a
Oct 27, 2017
Maintained: Hold
Price Target: $108 → $120
Current: $138.03
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $100 → $120
Current: $186.82
Upside: n/a
Jun 22, 2017
Maintained: Buy
Price Target: $16
Current: $68.14
Upside: n/a
May 22, 2017
Upgraded: Buy
Price Target: $47 → $50
Current: $15.81
Upside: n/a
Jan 18, 2017
Maintained: Buy
Price Target: $200
Current: $232.64
Upside: n/a
Nov 30, 2016
Upgraded: Hold
Price Target: n/a
Current: $182.07
Upside: n/a
Nov 16, 2016
Reiterated: Sell
Price Target: $14 → $2
Current: $7.77
Upside: n/a